Absci Corp
ABSI
Company Profile
Business description
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
Contact
18105 SE Mill Plain Boulevard
VancouverWA98683
USAT: +1 360 949-1041
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
157
Stocks News & Analysis
stocks
Market pricing in further upside in overvalued ASX bank
We view the shares are materially overvalued.
stocks
Chart of the Week: Lithium is rebounding on rising demand
The mining sector is significantly overvalued on average but select value to be found.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,238.70 | 21.50 | 0.23% |
| CAC 40 | 8,429.03 | 0.00 | 0.00% |
| DAX 40 | 25,278.21 | 279.81 | 1.12% |
| Dow JONES (US) | 49,662.66 | 129.47 | 0.26% |
| FTSE 100 | 10,686.18 | 130.01 | 1.23% |
| HKSE | 26,705.94 | 138.82 | 0.52% |
| NASDAQ | 22,753.63 | 175.25 | 0.78% |
| Nikkei 225 | 57,143.84 | 577.35 | 1.02% |
| NZX 50 Index | 13,262.74 | 15.72 | 0.12% |
| S&P 500 | 6,881.31 | 38.09 | 0.56% |
| S&P/ASX 200 | 9,007.00 | 12.80 | 0.14% |
| SSE Composite Index | 4,082.07 | 51.95 | -1.26% |